Formulary Search Results for: SODIUM ZIRCONIUM CYCLOSILICATE emergency
9.2.1.1 Oral potassium - View Category
7.5.3 Cation exchange compound - View Category
Restrictions:
Restricted to specialist initiation in patients with hyperkalaemia (serum potassium >6.0mmol/L) with chronic kidney disease (CKD) stage 3b to 5 and/or heart failure who would otherwise need to down-titrate or discontinue their renin-angiotensin-aldosterone system inhibitor (RAASi) therapy to maintain a clinically acceptable serum potassium level.
Prescribing Notes:
Please refer to section 9.2.1.1 for treatment of acute, life-threatening hyperkalaemia.
9.2.1.1 Oral potassium - View Category
Restrictions:
Restricted to specialist initiation in patients with hyperkalaemia (serum potassium >6.0mmol/L) with chronic kidney disease (CKD) stage 3b to 5 and/or heart failure who would otherwise need to down-titrate or discontinue their renin-angiotensin-aldosterone system inhibitor (RAASi) therapy to maintain a clinically acceptable serum potassium level.
12.3.1 Drugs for oral ulceration and inflammation - View Category
Restrictions:
Restricted to use only for oral ulceration
Prescribing Notes:
This is an unlicensed use of betamethasone soluble tablets. The tablets should be dissolved in around 20 ml of water to create a mouthwash, then rinsed around the mouth and not to be swallowed. See BNF for further detail.
12.3.4 Mouthwashes, gargles, and dentifrices - View Category
11.4.1 Eye-corticosteroids - View Category
9.1.1.1 Oral iron - View Category
9.2.1.2 Oral sodium and water - View Category
9.5.3 Fluoride - View Category
5.1.7 Some other antibacterials - View Category
Restrictions:
Restricted to specialist initiation where nebulised colistimethate is not tolerated and tobramycin is being considered.